This message was posted by a user wishing to remain anonymous
Hello,
I have a major protocol amendment to submit to the FDA (dose change request). For this, should I submit to the FDA for review and the central IRB at the same time, or, do I need to obtain the FDA approval of the protocol amendment before submitting to the IRB? I can't seem to locate anything conclusive on this. Thank you!